People over 50 fear shingles because of the nerve pain, which can last months or years after the rash has gone. There are now two vaccines, and they differ in how they work, how well they protect and what they cost. Below they are compared point by point, with advice on who should choose which.
Key takeaways
- Shingrix is a non-live recombinant vaccine given in two doses, with timing depending on health. Trials in immunocompetent adults aged50+ found protection above90%, but results vary by population and do not guarantee individual protection.
- The live vaccine (Zostavax): a single dose, about 50% protection that wanes, and not for anyone immunocompromised.
- Thai Shingrix registration indicates adults50+ and adults18+ at increased risk of shingles. Suitability and the actual label require assessment; U.S. guidance is not the Thai licensing standard.
- Prices at the clinic: live 5,000 baht/dose · recombinant 6,900 baht/dose (2-dose package 13,000 baht)
What shingles is and why prevent it
Shingles results from reactivation of varicella-zoster virus remaining in the body after chickenpox. Risk increases with age and immune conditions. CDC’s approximately one-in-three lifetime estimate concerns theU.S.population, not an individual Thai patient.
Postherpetic neuralgia can persist for months or years and affect daily life. Prevention and treatment assessment serve different purposes; vaccination does not treat acute shingles or existing neuralgia.
Sources: [1] U.S. Centers for Disease Control and Prevention, [4] U.S. Centers for Disease Control and Prevention
The two vaccines compared

Scroll sideways to read the full table →
| Live attenuated | Recombinant (non-live) | |
|---|---|---|
| Brand | Zostavax | Shingrix |
| How it works | Weakened virus, provokes immunity like natural infection | Viral protein plus an adjuvant; contains no live virus |
| Doses | 1 dose | Two doses; usually2–6months, or1–2months for selected immunocompromised patients after assessment |
| Protection against shingles | Varies by age and study; wanes over time | Over 90% in trials of immunocompetent adults 50+; results vary by immune status |
| Protection against post-herpetic neuralgia | Reduced risk in studied groups; no guarantee | Reduced risk in studied groups; no guarantee |
| Durability | Wanes clearly after 5–8 years | Protection persists for years; duration depends on population and study |
| Age | Check the actual live-product label and immune status | Thai Shingrix registration:50+,or18+at increased risk;assessment required |
| Not for | Immunocompromised, on immunosuppressants, pregnant | Check severe allergy, current shingles, pregnancy and individual clinical circumstances |
| Typical side effects | Injection-site pain, redness, itch, headache; fairly mild | Quite sore arm, tiredness, aches, fever for 1–3 days |
| Price at the clinic | 5,000 baht/dose | 6,900 baht/dose · 2-dose package 13,000 baht |
Sources: [1] U.S. Centers for Disease Control and Prevention, [2] U.S. Centers for Disease Control and Prevention (MMWR), [4] U.S. Centers for Disease Control and Prevention, [5] Thai Food and Drug Administration, [6] Thai Food and Drug Administration
Which to choose
U.S. CDC recommends Shingrix for immunocompetent adults50+ and selected immunodeficient or immunosuppressed adults from19. Thai indications differ in detail. A clinician must coordinate timing with disease and treatment; being non-live does not establish immediate suitability for every immunocompromised person.
Bring the product name and date of any live vaccine. CDC specifies at least eight weeks between Zostavax and Shingrix, but the actual products and applicable Thai guidance must be checked. Do not add doses based only on a “live vaccine” description.
Good to know: CDC does not require a routine one-year wait for Shingrix after shingles, but it should not be given during an acute episode. The treating clinician should assess recovery, health and the actual product before scheduling.
Sources: [4] U.S. Centers for Disease Control and Prevention, [5] Thai Food and Drug Administration, [6] Thai Food and Drug Administration
What to expect after the recombinant vaccine

- Shingrix may cause local pain, redness or swelling, fatigue, muscle aches, headache or fever. These can disrupt activities and often improve within a few days.
- Do not assume every symptom is an expected immune response. Contact the provider if symptoms are severe, worsening or not improving; difficulty breathing, facial or throat swelling, or loss of consciousness requires emergency help.
- Ask about aftercare and pain medicine suitable for your conditions and current medicines. Reactions to dose2 are not guaranteed to match dose1.
- Serious reactions are very rare; the clinic keeps you for observation after the injection
Sources: [1] U.S. Centers for Disease Control and Prevention, [5] Thai Food and Drug Administration
Booking, and combining with other vaccines
Coadministration needs assessment of the actual product pair; do not assume both live and recombinant products work with every vaccine. The cited Thai Shingrix document identifies studied combinations at separate sites and notes more fever/chills withPPV23. Discuss health and tolerability first. See senior vaccines, non-live shingles vaccination or live vaccination. Send age, conditions and prior vaccines viaLINE to check stock and plan.
Good to know: Sources naming Shingrix or Zostavax do not establish the clinic’s stocked brand. The cited Thai document is theMay2024edition; verify the current label of the actual supplied product.
Sources: [4] U.S. Centers for Disease Control and Prevention, [5] Thai Food and Drug Administration
Frequently asked questions
At Mongkhondee Clinic the live vaccine is 5,000 baht/dose (single dose) and the recombinant vaccine 6,900 baht/dose, or 2-dose package 13,000 baht, including doctor and nursing fees.
Related services
Related vaccines
Related articles
Sources
- [1] Shingles Vaccination: What Everyone Should Know U.S. Centers for Disease Control and Prevention
- [2] Recommendations of the Advisory Committee on Immunization Practices for Use of Herpes Zoster Vaccines U.S. Centers for Disease Control and Prevention (MMWR)
- [3] สมุดวัคซีนสำหรับผู้ใหญ่และผู้สูงอายุ (พฤษภาคม 2568) สมาคมโรคติดเชื้อแห่งประเทศไทยAccessed 11 October 2026
- [4] Shingles Vaccine Recommendations: U.S. timing and coadministration U.S. Centers for Disease Control and PreventionAccessed 12 October 2026
- [5] Shingrix Thai product information, May 2024 edition Thai Food and Drug AdministrationAccessed 12 October 2026
- [6] Shingrix Thai registration 1C9/66(NBC): indications Thai Food and Drug AdministrationAccessed 12 October 2026
This content is general information and does not replace an examination, diagnosis or personal advice from a doctor. Published 21 September 2026
How we select sources and handle corrections
